

Cover Story
COVID-19 & CancerFree
By Matthew Bin Han Ong
Community oncology practices in the United States are reeling from a sharp decrease in business—whether you look at new patients, chemotherapy visits, or non-chemo visits—the result of reduced activity and stay-at-home orders across the country to mitigate the spread of SARS-CoV-2.
COVID-19 Updates
In Brief
Clinical Roundup
Drugs & Targets
Trending Stories
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - NIH Director Jay Bhattacharya launches a podcast
- Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures
- In the Headlines: What if curing diseases was treated like a business?
- As Trump decimates NIH funding, a daring proposal to issue $750 billion in bonds for medical cures garners attention
- How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest